Since 2007, StoneArch has been partnering with clients in the advancement of the heart failure space, from the market-changing indications brought forth by MADIT-CRT to the life-changing impact of an LVAD that reduces red blood cell damage. Through our newest partnership with St. Jude Medical, we’ll be bringing awareness and clarity to the challenge of CRT non-responders. We’re excited about the opportunity to learn more about the challenging disease-state and to help our clients do more for this growing patient population.